Apicule is a pioneering platform revolutionizing the pharmaceutical supply chain by streamlining the sourcing and trading of Active Pharmaceutical Ingredients (APIs) also known as drug substances. As a trusted intermediary, we connect pharmaceutical manufacturers, research institutions, and healthcare providers with reputable API suppliers worldwide. Our comprehensive database and advanced search capabilities enable our clients to efficiently navigate the complex landscape of API procurement, ensuring access to high-quality ingredients that meet stringent regulatory standards. At Apicule, we understand that the quality of APIs directly impacts the safety and efficacy of final drug products. Therefore, we meticulously vet our network of suppliers, considering factors such as quality assurance, regulatory compliance, and supply chain resilience. By leveraging our expertise and cutting-edge technology, we empower our clients and drug product manufacturers to make informed decisions, mitigate risks, and ultimately contribute to the development of safe and effective medications for patients globally.
Patheon Pharma Services, a subsidiary of Thermo Fisher Scientific, is a leading Contract Development and Manufacturing Organization (CDMO) that provides comprehensive solutions for drug development, clinical trial logistics, and commercial manufacturing. Since its acquisition by hermo Fisher Scientific in 2017, Patheon has become a cornerstone of the company's Pharma Services division, offering end-to-end capabilities to pharmaceutical, biotech, and life sciences industries. Patheon Pharma Solutions has its headquarters located at 168 Third Avenue, Waltham, Massachusetts, USA 02451. - Show More
Pharmaceutical companies trust CIMA delivery technologies to commercialize new drugs and extend the product life cycle of established brands. CIMA specializes in orally disintegrating tablet (ODT), oral transmucosal (OTM) and oral powder drug delivery technologies. In addition, C MA has expertise in taste-masking and customized release profiles. Historical highlights: 1986 Business founded 1988 First generic product launch 1...Pharmaceutical companies trust CIMA delivery technologies to commercialize new drugs and extend the product life cycle of established brands. CIMA specializes in orally disintegrating tablet (ODT), oral transmucosal (OTM) and oral powder drug delivery technologies. In addition, CIMA has expertise in taste-masking and customized release profiles. Historical highlights: 1986 Business founded 1988 First generic product launch 1993 First ODT patent 1994 IPO 1997 First OTC ODT product launch 1999 First Rx ODT product launch 2000 Cephalon acquires Anesta company (OTS technology) 2001 Cephalon acquires Lafon company (Lyoc technology) 2004 Cephalon acquires CIMA (ODT and oral transmucosal technologies) 2004 First Rx bottled ODT U.S. product launch 2006 First OraVescent product launch 2007 All Cephalon’s drug delivery technologies are consolidated under CIMA - Show More
Jost Chemical Co. is an FDA-registered, privately held manufacturer of high purity inorganic specialty chemicals and minerals. Founded in 1985 and headquartered in St. Louis, Missouri, Jost Chemical produces over 150 products primarily for pharmaceutical, biotech, nutritional, an food markets. Their products include USP/NF/EP grade ingredients used as process intermediates in drugs and as minerals in infant formula, supplements, and toothpaste. - Show More
Viatris Inc. is a global healthcare company headquartered in Canonsburg, Pennsylvania, USA. Formed in November 2020 through the merger of Mylan and Pfizer’s Upjohn division, Viatris operates as a major player in both generic and branded pharmaceuticals, as well as biosimilars a d active pharmaceutical ingredients (APIs). - Show More
Luitpold Pharmaceuticals, Inc. was a U.S. pharmaceutical company that was a subsidiary of the Japanese company Daiichi Sankyo. The company was a manufacturer and distributor of both branded and generic pharmaceuticals, specializing in injectable products. In 2019, Luitpold Pharma euticals underwent a significant restructuring. It merged with its own subsidiaries, American Regent, Inc. and PharmaForce, Inc., and officially changed its name to American Regent, Inc. The name change was a strategic move to consolidate its brand identity, as American Regent was the market-facing brand for products that generated over 95% of Luitpold's revenue at the time. Today, the company operates under the name American Regent, Inc. It continues to be a Daiichi Sankyo Group company, focusing on the development, manufacturing, and marketing of a range of products - Show More
Together we deliver life-saving therapies to patients in need. With the commitment and drive you bring to the workplace every day, you will be part of a team that is changing the world and helping millions of people live healthier, more fulfilling lives. Our worldwide staff of mo e than 9,000 people is a close community where you can see the tangible results of your contributions, where every individual matters, and everyone h...Together we deliver life-saving therapies to patients in need. With the commitment and drive you bring to the workplace every day, you will be part of a team that is changing the world and helping millions of people live healthier, more fulfilling lives. Our worldwide staff of more than 9,000 people is a close community where you can see the tangible results of your contributions, where every individual matters, and everyone has a chance to enhance their skills through ongoing development. Our scientific focus has resulted in 23 marketed products that are benefiting millions of people, a pipeline of late-stage drug candidates. - Show More
E.R. Squibb & Sons Inc is a historic American pharmaceutical company, founded by Dr. Edward Robinson Squibb in 1858 in Brooklyn, New York. Dr. Squibb, a former Navy doctor, was renowned for his advocacy of pharmaceutical purity and safety, pioneering processes for making pure eth r and other medicines. In 1989, E.R. Squibb & Sons merged with Bristol-Myers, forming Bristol-Myers Squibb—one of the world’s leading biopharmaceutical companies today. The Squibb name remains part of the Bristol-Myers Squibb corporate identity, and the company’s legacy continues through its contributions to pharmaceutical research, development, and manufacturing. - Show More
We’re engineers, scientists, operators and product developers. We’re innovators, advisers, designers and problem solvers. Most importantly, we’re partners – in creating value for our customers with the solutions we offer and in improving the world through the actions of o r colleagues. Celanese is The Chemistry Inside Innovation™ and we aspire to be the first-choice chemistry solution source for our customers. - Show More
At Asymchem we are proud of the strides that we have made since our founding in 1999, providing R&D and one-stop production services to the world’s top pharmaceutical companies. Driving our success is our commitment to continual optimization and investing in the future. By impr ving the capabilities our partners need now, and maintaining the agility needed to support innovation, we’ve built a knowledge and experience base ...At Asymchem we are proud of the strides that we have made since our founding in 1999, providing R&D and one-stop production services to the world’s top pharmaceutical companies. Driving our success is our commitment to continual optimization and investing in the future. By improving the capabilities our partners need now, and maintaining the agility needed to support innovation, we’ve built a knowledge and experience base that we’re ready to share. - Show More
